Search Results for 'patients'
Contract Service Directory Companies
View All Buyers Guide Companies »
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings
Roche’s Ronapreve Reduces Viral Load in COVID-19 Patients
Phase II/III trial met primary endpoint, showing Ronapreve significantly reduced viral load in patients hospitalized with COVID-19.09.30.21
-
Breaking News | Drug Development | Industry News
Veklury Reduced Risk of Hospitalization in High-Risk COVID-19 Patients
Veklury demonstrated a statistically significant 87% reduction in risk for the composite primary endpoint of COVID-19 related hospitalization.09.22.21
-
Breaking News | Collaborations & Alliances
Cellenkos Chooses Cryoport to Support Covid-19 Therapy Shipments to Patients
Cryoport will provide tracking and proactive management for the therapies.06.22.21
-
-
Drug Delivery | Injectables
Self-Medication: Flexibility for Patients and Drug Manufacturers
Bringing together self-medication with auto-injectors and sustainable secondary packaging.Matthias Heinrichs, Head of Product Management and Project Engineering, Syntegon Technology 11.17.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Lilly Pauses ACTIV-3 Clinical Trial in Hospitalized COVID-19 Patients
ACTIV-3 study is evaluating the efficacy of Lilly’s neutralizing antibody in hospitalized COVID-19 patients, the most advanced stage of the disease.Contract Pharma Staff 10.16.20
-
Breaking News | Collaborations & Alliances | Industry News
Ethypharm and RSSL Fast-Track Medicine for COVID-19 Patients
Collaborate to accelerate the manufacture and batch release of fentanyl injectionContract Pharma Staff 06.04.20
-
Toronto centre solving cell manufacturing challenges to benefit patients and global industry
CCRM and Cytiva, formerly part of GE Healthcare Life Sciences, renew collaboration agreement for Centre for Advanced Therapeutic Cell Technologies
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Lilly, AbCellera Dose First Patients with COVID-19 Antibody
Phase 1 study of LY-CoV555 is the world's first study of a potential antibody treatment designed to fight COVID-19Contract Pharma Staff 06.01.20
-
Breaking News | Drug Development | Trials & Filings
CTI BioPharma Initiates Phase III Pacritinib Trial in COVID-19
Will compare pacritinib plus standard of care versus placebo plus standard of care in 358 patients with severe COVID-19.Contract Pharma Staff 04.27.20
-
Breaking News | Industry News
FDA COVID-19 Update
FDA issues a Drug Safety Communication regarding known side effects of hydroxychloroquine and chloroquineContract Pharma Staff 04.27.20
-
Breaking News | Drug Development | Industry News
Santhera, CSHL to Investigate Lonodelestat in COVID-19-related ARDS
Lonodelestat (POL6014), a potent inhibitor of human neutrophil elastase (hNE), has potential as a therapeutic intervention for COVID-19-related ARDS.Contract Pharma Staff 04.27.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings
Regeneron, Sanofi Release Preliminary Phase II Kevzara Results in COVID-19
Kevzara rapidly lowered C-reactive protein (CRP), a key marker of inflammation, meeting the primary endpoint.Contract Pharma Staff 04.27.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Cytovance and Akshaya Enter Vaccine Collaboration
Partnership to focus on therapeutics for treatment of coronavirus and hepatitis B virus infectionsContract Pharma Staff 04.24.20
-
Breaking News | Collaborations & Alliances | Industry News
CMIC Supports Avigan Production for Potential COVID-19 Treatment
Includes clinical trials and manufacturing of influenza antiviral drug for COVID-19 patientsContract Pharma Staff 04.24.20
-
Bio News | Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
Samsung Biologics, ImmuneOncia Reach Regulatory Milestone
Development and manufacturing agreement accomplishes IND clearance of IMC-002 (anti-CD47 antibody)Contract Pharma Staff 04.24.20
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Drug Development | Trials & Filings
Theravance Initiates Study in ALI caused by COVID-19
TD-0903 has potential to inhibit cytokine storm associated with ALI and prevent progression to Acute Respiratory Distress Syndrome04.23.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
ProThera, Takeda Enter Anti-Inflammatory Alliance
To develop a novel plasma-derived Inter-alpha Inhibitor Proteins therapy for the treatment of acute inflammatory conditionsContract Pharma Staff 04.23.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings
Novartis’ Kymriah Gets RMAT Designation
Investigational new indication to treat patients with relapsed or refractory follicular lymphomaContract Pharma Staff 04.22.20
-
Breaking News | Drug Development | Industry News
AskBio Acquires BrainVectis
Expands clinical pipeline for neurodegenerative diseases with Huntington’s disease gene therapy candidateContract Pharma Staff 04.22.20
-
Breaking News | Drug Development | Industry News
Pharnext, UHI to Evaluate Repurposed Drugs Against COVID-19
Aims to rapidly test several approved drugs as potential candidates for fighting COVID-19 using big data and artificial intelligenceContract Pharma Staff 04.22.20
-
New iPSC Master Cell Banks to Accelerate Development of Novel Cell Therapies
panCELLa and CCRM collaborate to benefit academia and industry
-
Breaking News | Promotions & Moves
ADC Therapeutics Appoints Jennifer Creel as CFO
Former Celgene executive brings deep oncology-focused financial expertiseContract Pharma Staff 04.21.20
-
Drug Development | GMPs/GCPs | Regulatory Affairs
FDA’s Emergency Use Authorizations
Aggressive Action Taken to Combat COVID-19Chad Landmon and Drew Hillier, Axinn, Veltrop & Harkrider LLP 04.20.20
-
Breaking News | Trials & Filings
Oral Anti-Viral for Covid-19 Filed under FDA’s CTAP
BioSig’s Vicromax is an orally administered drug that could be delivered to patients during all stages of Covid-19Contract Pharma Staff 04.20.20
-
Breaking News | Trials & Filings
4D Pharma Begins Phase II COVID-19 Study
MRx-4DP0004, an immunomodulatory therapy, has shown potential to down-regulate hyper-inflammatory response while maintaining anti-viral responseContract Pharma Staff 04.20.20
-
Breaking News | Industry News
FDA COVID-19 Update
Public-private partnership with the FDA and others aims to speed the development of COVID-19 vaccine and treatment options.Contract Pharma Staff 04.20.20
-
APIs | Breaking News | Industry News
Wavelength Ups API Production for Essential Respiratory Meds
Products in demand due to coronavirus pandemic include Midazolam, Cisatracurium, and Rocuronium.Contract Pharma Staff 04.20.20
-
-
Breaking News | Collaborations & Alliances | Industry News
Kaneka to Supply API for Fujifilm’s Avigan Tablet
Production of Avigan being ramped up for COVID-19 patientsContract Pharma Staff 04.17.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News
AzurRx, Delpharm Enter Manufacturing Agreement
For the clinical drug product supply of MS1819 therapy for exocrine pancreatic insufficiencyContract Pharma Staff 04.17.20
-
Breaking News | Collaborations & Alliances | Industry News
Evotec, leon-nanodrugs Enter Nanomedicine Pact
Evotec makes strategic investment in leon by leading the company's Series B funding roundContract Pharma Staff 04.17.20
-
Breaking News | Industry News
Eagle Pharma’s Drug Shows Antiviral Activity Against COVID-19
IND submitted to FDA for clinical study at Hackensack University Medical Center to evaluate Ryanodex for treatment of COVID-19 patientsContract Pharma Staff 04.17.20
-
Breaking News | Clinical Trials | Industry News
Octapharma Supports New COVID-19 Trial
Aims to assess if Intravenous Immunoglobulin (IVIG) can halt coronavirus progression to respiratory failureContract Pharma Staff 04.16.20
-
Breaking News | Clinical Trials | CRO News | Drug Development
PPD’s AES Biz Launches Patient-Transfer Program
Supports clinical trial continuity for biopharma companies during COVID-19 pandemic by transferring clinical trial patients to AES’ dedicated research sitesContract Pharma Staff 04.16.20
-
Clinical Trials | Drug Development
How to Design Trials to be More Patient-Centered
Three lessons learned and how pharma can use validated measures and strategies to engage patients at every stage in the drug development lifecycle.Jean Paty, Vice President, Patient Centered Sciences, IQVIA, Matthew Reaney, Senior Principal, Patient Centered Sciences, IQVIA 04.16.20
-
Bio News | Breaking News | Industry News | Inspections
WuXi Biologics Passes EMA GMP Inspection
Suzhou site clears regulatory hurdle with not critical findingsContract Pharma Staff 04.15.20
-
Breaking News | Industry News
Fujifilm Boosts Production of Avigan Tablet for COVID-19
Expands manufacturing capacity at Fujifilm Toyama Chemical to increase production of its influenza antiviral drugContract Pharma Staff 04.15.20
-
Breaking News | Industry News
MedPharm Helps Fight COVID-19 Outbreak
Donates hand sanitizer for healthcare providers and other essential workersContract Pharma Staff 04.15.20
-
Breaking News | Industry News | Laboratory Testing
Abbott Launches Third COVID-19 Test
To distribute 4 million tests in April, ramping to 20 million in the U.S. per month in June and beyondContract Pharma Staff 04.15.20
-
Breaking News | Industry News
Centogene Opening Lab to Increase COVID-19 Testing
Acquiring former laboratory facilities and equipment of Provecs Medical GmbH in Hamburg, GermanyContract Pharma Staff 04.15.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer
Jenner Institute, MilliporeSigma to Scale Up Covid-19 Vax Production
Develops a rapid, scalable platform following good manufacturing practices and using disposable technologies.Contract Pharma Staff 04.14.20
-
CytoSorbents Gets EUA for Blood Purification Technology
CytoSorb can be used treat cytokine storm and deadly inflammation in critically-ill COVID-19 patientsContract Pharma Staff 04.13.20
-
FDA COVID-19 Update
Issues EUA for blood purification system to treat COVID-19 patientsContract Pharma Staff 04.13.20
-
Breaking News | Clinical Trials | Drug Development | Industry News
Lilly, NIAID to Study Baricitinib in COVID-19
Baricitinib's anti-inflammatory activity has been hypothesized to have a potential benefit in COVID-19Contract Pharma Staff 04.13.20
-
Clinical Trials | Drug Development
Gilead’s Remdesivir Shows Promise in Severe COVID-19 Cohort
Early analysis shows clinical improvement was observed in 36 of 53 patients, or 68%Contract Pharma Staff 04.13.20
-
Drug Development | R&D
COVID-19 and the Importance of Combating Antimicrobial Resistance
Dr. Frank of Working to Fight AMR discusses the global COVID-19 pandemic and the critical need to address the public health crisis of Antimicrobial ResistanceOnline Exclusives Kristin Brooks, Contract Pharma 04.13.20
-
Breaking News | Facilities | Industry News
ISPE Award Honors New Pfizer Facility
Engineered and designed by CRB, Andover Clinical Manufacturing Facility focuses on integration and flexibility to speed patient therapiesContract Pharma Staff 04.13.20
-
Breaking News | Clinical Trials | Industry News | Information Technology
Cytel Launches COVID-19 Clinical Trial Tracker
Facilitates collaboration between researchers, policymakers, clinicians, journalists, philanthropists, and other critical stakeholdersContract Pharma Staff 04.13.20
-
Breaking News | Industry News
Pfizer Advances Battle Against COVID-19 on Multiple Fronts
Anti-viral compounds show activity against SARS-CoV-2 in preclinical screeningContract Pharma Staff 04.13.20
